For Schedule III through V transfers to a reverse distributor, which details must be included in the record?

• A. Drug name, dosage form, drug strength, quantity, and date transferred.
• B. Drug name and quantity only.
• C. Drug strength and date transferred only.
• D. Drug name, dosage form, and date transferred.

Answer: (A)

Accurate traceability is required when moving Schedule III–V drugs to a reverse distributor. The record must capture the exact product being transferred, including its name, dosage form, and strength, along with the quantity and the date of transfer. This combination uniquely identifies the item and creates a verifiable trail for inventory reconciliation, disposal, and regulatory audits. If any of these details were omitted—for example, only the name or only the date were recorded—the record could not precisely identify which product and how much was moved, making audits and recalls much more difficult.